Illumina and PacBio Sequencing of Human and Mouse DNA and RNA

Department of Health (HC)
CanadaBuys Posted: November 3, 2026

Location: Ontario, Canada

Due Date
December 10, 2026
(21 days left)
Solicitation #
1000273702

Actions

Email me bids like this (free)

Paste your website. We'll send matching US & Canadian bids every morning.

or
Or get a go/no-go analysis of this bid

Documents (3)

Downloads need a free Narwin account.

  • 1000273702_complete-rfp-(final-(en-(amendmen-1.pdf
    PDF · 800.9 KB
  • 1000273702_bidder-q-a-1.pdf
    PDF · 247.2 KB
  • 1000273702_complete-rfp-(final(en.pdf
    PDF · 801.6 KB

Description

Read full description

The Mechanistic Studies Division (MSD) of Health Canada’s Environmental Health Research and Science Bureau investigates the pathways by which physical, chemical and microbiological agents can cause adverse health effects. To determine how chemical substances cause DNA damage that can lead to illnesses like cancer or inherited diseases, MSD requires high-throughput genome sequencing services utilizing Illumina and Pacific Biosciences (PacBio) platforms. The primary objective of this contract is to secure long-term high-quality sequencing services for pre-prepared DNA libraries and genomic DNA and/or RNA utilizing Illumina or PacBio Revio platforms for the full duration of projects funded until up to 2030-2031. This requirement encompasses the sequencing of multiple mouse and human error-corrected next-generation sequencing (ecNGS) DNA libraries, genomic DNA and/or RNA samples in direct support of four distinct research projects. These projects are distributed across the Division and funded through three separate programs. Collectively, they employ advanced genomic technologies to support public health protection by identifying environmental mutagens, evaluating occupational hazards, and improving toxicological testing methodologies. Specifically, this work will use ecNGS, whole-genome sequencing (WGS), whole-exome sequencing and/or RNA-sequencing approaches to detect and characterize both spontaneous mutations and mutations induced by chemical and environmental exposures in mouse and human DNA as well as gene expression changes. The resulting data will contribute to a better understanding of mutagenic mechanisms, exposure-related genetic damage, and the development of more sensitive and informative approaches for genetic toxicology and human health risk assessment.

Additional Information

Source

canadabuys

Status

open

Procurement Method

Competitive - Open bidding

Procurement Category

Services

Selection Criteria

Lowest Price

Regions of Opportunity

National Capital Region (NCR)

Regions of Delivery

Chile *South Korea *United States of America *Peru *Honduras *Europe *Canada *Colombia *Panama

Reference Number

cb-321-95217286

Amendment Number

001

Contracting Entity

Department of Health (HC)

Contact Name

Wesley Phillips

Contact Email

Contact Country

Canada

Organization City

Ottawa

Organization Province / State

Ontario

Organization Country

Canada

Last Updated

November 17, 2026

Frequently Asked Questions

When is the proposal submission deadline?

The proposal submission deadline is December 10, 2026 (21 days left).

Where can I submit a proposal or get solicitation documents?

You can access the full solicitation documents and submit your proposal at the official source:

Visit Official Source

Open bids from this agency

All tenders from Department of Health (HC) 73 past tenders

Get new bids from this agency by email

Follow for free

Narwin checks SAM.gov, CanadaBuys, BC Bid and 50+ city portals daily and emails you only the bids that fit your business. Disclaimer: This bid/tender/opportunity information is presented as is and may be incorrect at times. Please read the tender documents carefully before finalizing bids. We do not accept any responsibility and cannot be held legally liable for any inaccuracies.